APA (7th ed.) Citation

JHA, C., SA, P., S, J., TV, K., T, T., V, A., . . . A, H. (2026). Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors. Molecular therapy : the journal of the American Society of Gene Therapy, 34(5), 3056. https://doi.org/10.1016/j.ymthe.2026.01.019

Chicago Style (17th ed.) Citation

JHA, Clubb, et al. "Dyslipidemia-associated Natural IgM Improves Oncolytic Virus TILT-123 Efficacy Through Antibody-dependent Enhancement in Solid Tumors." Molecular Therapy : The Journal of the American Society of Gene Therapy 34, no. 5 (2026): 3056. https://doi.org/10.1016/j.ymthe.2026.01.019.

MLA (9th ed.) Citation

JHA, Clubb, et al. "Dyslipidemia-associated Natural IgM Improves Oncolytic Virus TILT-123 Efficacy Through Antibody-dependent Enhancement in Solid Tumors." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 34, no. 5, 2026, p. 3056, https://doi.org/10.1016/j.ymthe.2026.01.019.